Trials / Active Not Recruiting
Active Not RecruitingNCT06709729
Switch of AndroidAPS to Commercially Available AID Systems
Switch of Open-source Automated Insulin Delivery System - AndroidAPS to Commercially Available AID Systems in Type 1 Diabetes: the Extension of the CODIAC Study
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 41 (estimated)
- Sponsor
- Charles University, Czech Republic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study was to investigate the switch between open-source automated insulin delivery system (OS-AID) - AndroidAPS (AAPS) and commercially available AID systems - Control-IQ (CIQ) and MiniMed 780G (780G) in extended follow-up study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Insulin pump with closed-loop system | Device: Usage of Insulin pump t:slim X2 with Control-IQ technology or MiniMed 780G with Smartguard technology in previous users of AndroidAPS |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2024-12-01
- Completion
- 2024-12-31
- First posted
- 2024-11-29
- Last updated
- 2024-11-29
Locations
1 site across 1 country: Czechia
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06709729. Inclusion in this directory is not an endorsement.